Tubulis Technologies
Pre-clinicalReimagining Antibody Drug Conjugates NEWS January 27 Tubulis Adds Steve Kelsey as Independent Director to its Advisory Board January 21 Tubulis Unveils Alco5 Conjugation Platform’s Ability to Expand ADC Payload Scope in Nature Communications January 08 Tubulis Appoints Charles Fuchs, MD as Chief Medical Officer to Lead Clinical Strategy and Pipeline Development 1 / 3 […]
About
Reimagining Antibody Drug Conjugates NEWS January 27 Tubulis Adds Steve Kelsey as Independent Director to its Advisory Board January 21 Tubulis Unveils Alco5 Conjugation Platform’s Ability to Expand ADC Payload Scope in Nature Communications January 08 Tubulis Appoints Charles Fuchs, MD as Chief Medical Officer to Lead Clinical Strategy and Pipeline Development 1 / 3 […]
Funding History
3Total raised: $208.7M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile